13th Aug 2025 13:51
Hikma Pharmaceuticals PLC - PDMR Exercise of Share Awards
LONDON, 13 April 2025: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Person Discharging Managerial Responsibility ("PDMR") has received shares and sold sufficient to cover tax as a result of the exercise of options granted at nil-cost on 17 March 2016, 13 April 2017 and 16 May 2018 under the 2014 Executive Incentive Plan ("EIP").
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Susan Ringdal | |
2 | Reason for the notification | ||
a) | Position/status | PDMR | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Hikma Pharmaceuticals PLC | |
b) | LEI | 549300BNS685UXH4JI75 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Acquisition of Shares pursuant to the exercise of options granted at nil-cost under the EIP | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil | 60,225 | ||
d) | Aggregated information | Price(s): nil Volume(s): 60,225 | |
e) | Date of the transaction | 12 August 2025 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares sold to cover tax following the exercise of options granted at nil-cost under the EIP. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
£17.76 | 28,393 | ||
d) | Aggregated information | Price(s): £17.76 Volume(s): 28,393 Total(s): £504,191.77 | |
e) | Date of the transaction | 12 August 2025 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
Helen MiddlemistGroup Company Secretary
+44 (0)20 7399 2760
Related Shares:
Hikma Pharmaceuticals